Seismic Therapeutic™ is transforming immunology therapy discovery and development with machine learning. It unites immunology, machine learning, and entrepreneurship experts to explore new drug discovery avenues, focusing on autoimmune and immunological diseases. Guided by seasoned leaders and leveraging its machine-learning IMPACT platform, Seismic aims to develop innovative biologics that regulate adaptive immunity. This patient-focused company is poised to significantly advance in treating autoimmune diseases through its dedication to uncovering new biology and its robust pipeline.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/04/2023 | Series B | $146.28MM | $xx.xx | $396.35MM | Alexandria Venture Investments, Amgen Ventures, Bessemer Venture Partners, Boxer Capital, Codon Capital, Gaingels, Gc&H, Gv, Lightspeed Venture Partners, Polaris Partners, Samsara Biocapital, Timothy A. Springer | |
Price per Share
$xx.xx
Shares Outstanding
32,392,769
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Amgen Ventures, Bessemer Venture Partners, Boxer Capital, Codon Capital, Gaingels, Gc&H, Gv, Lightspeed Venture Partners, Polaris Partners, Samsara Biocapital, Timothy A. Springer
|
||||||
02/09/2022 | Series A-2 | $11.38MM | $xx.xx | $210.35MM | Boxer Capital, Gv, Lightspeed Venture Partners, Polaris Partners, Samsara Biocapital, Timothy A. Springer | |
Price per Share
$xx.xx
Shares Outstanding
3,793,508
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Boxer Capital, Gv, Lightspeed Venture Partners, Polaris Partners, Samsara Biocapital, Timothy A. Springer
|
||||||
02/09/2022 | Series A-1 | $90MM | $xx.xx | $210.35MM | Boxer Capital, Gv, Lightspeed Venture Partners, Polaris Partners, Samsara Biocapital, Timothy A. Springer | |
Price per Share
$xx.xx
Shares Outstanding
22,499,998
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Boxer Capital, Gv, Lightspeed Venture Partners, Polaris Partners, Samsara Biocapital, Timothy A. Springer
|